Drug Delivery Scientists are key innovators in the pharmaceutical industry, specializing in developing systems that ensure drugs are effectively delivered to the right place in the body at the right time. Their work focuses on optimizing the pharmacokinetics and pharmacodynamics of medications, ensuring that drugs are absorbed, distributed, and released in the body to maximize therapeutic effect. These experts design and develop novel drug delivery technologies, including nanoparticles, liposomes, hydrogels, and microneedles, to overcome biological barriers, such as the blood-brain barrier or gastrointestinal tract, that often limit the effectiveness of conventional drug formulations. Their research is essential in improving the bioavailability and patient compliance of both small molecules and biologics.
Collaboration is a core aspect of their role, as drug delivery scientists often work with multidisciplinary teams, including chemists, biologists, clinicians, and engineers, to develop new delivery systems. They conduct rigorous preclinical and clinical studies to assess the safety, stability, and efficacy of drug formulations. Additionally, these specialists are involved in optimizing controlled-release systems, enhancing targeted delivery, and minimizing side effects by ensuring drugs reach only the targeted tissues or cells. As the field of personalized medicine expands, drug delivery scientists are increasingly focused on tailoring drug delivery systems to individual patient needs, ultimately improving outcomes in areas such as cancer, gene therapy, and chronic disease management.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico